MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2014.43%
Quick Ratio
2014.43%
Cash Ratio
622.83%
Debt to Asset Ratio
311.97%
Unit: Dollar
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
24,652,086
32,659,770
82,301,813
12,286,646
Marketable securities
50,615,164
45,405,126
-
-
Restricted cash
100,000
100,000
100,000
100,000
Prepaid expenses and other current assets
4,365,267
941,883
697,676
633,533
Total current assets
79,732,517
79,106,779
83,099,489
13,020,179
Equipment, net
-
-
0
1,360
Goodwill
14,869,399
14,869,399
14,869,399
14,869,399
Deferred offering costs
487,029
50,978
-
201,114
Total assets
95,088,945
94,027,156
97,968,888
28,092,052
Accounts payable
1,447,556
2,118,225
639,707
944,492
Accrued expenses and other current liabilities
2,510,505
2,363,968
1,650,766
1,727,830
Total current liabilities
3,958,061
4,482,193
2,290,473
2,672,322
Warrant liability
232,690,185
278,596,901
171,464,575
-
Liability related to the sale of future royalties
60,000,000
60,000,000
60,000,000
60,000,000
Total liabilities
296,648,246
343,079,094
233,755,048
62,672,322
Series a convertible preferred stock 0.0001 par value 200,000 shares authorized liquidation preference of 0 5,539 shares issued and outstanding as of june 30, 2026 and 3,296 shares issued and outstanding as of december 31, 2025
11,741,322
4,961,922
4,961,922
-
Common stock 0.0001 par value 250,000,000 shares authorized 47,227,259 shares issued and outstanding as of june 30, 2026 and 43,274,398 shares issued and outstanding as of december 31, 2025
4,723
4,384
4,327
699
Additional paid-in capital
583,432,493
560,185,880
548,047,331
370,551,108
Accumulated deficit
-796,737,839
-814,204,124
-688,799,740
-405,132,077
Total stockholders' deficit
-213,300,623
-254,013,860
-140,748,082
-34,580,270
Total liabilities, redeemable preferred stock and stockholders' deficit
95,088,945
94,027,156
97,968,888
28,092,052
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$50,615,164 Cash and cashequivalents$24,652,086 (61.68%↑ Y/Y)Prepaid expenses andother current assets$4,365,267 (2086.84%↑ Y/Y)Restricted cash$100,000 (0.00%↑ Y/Y)Total current assets$79,732,517 (412.83%↑ Y/Y)Goodwill$14,869,399 (0.00%↑ Y/Y)Deferred offering costs$487,029 Total assets$95,088,945 (212.59%↑ Y/Y)Accumulated deficit-$796,737,839 (-98.00%↓ Y/Y)Total liabilities,redeemable preferred stock...$95,088,945 (212.59%↑ Y/Y)Total stockholders'deficit-$213,300,623 (-564.30%↓ Y/Y)Additional paid-in capital$583,432,493 (57.57%↑ Y/Y)Common stock 0.0001 parvalue 250,000,000...$4,723 (575.68%↑ Y/Y)Total liabilities$296,648,246 (374.42%↑ Y/Y)Series a convertiblepreferred stock 0.0001 par...$11,741,322 Warrant liability$232,690,185 Liability related to thesale of future...$60,000,000 (0.00%↑ Y/Y)Total currentliabilities$3,958,061 (56.52%↑ Y/Y)Accrued expenses andother current...$2,510,505 (53.82%↑ Y/Y)Accounts payable$1,447,556 (61.41%↑ Y/Y)

Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences, Inc. (NERV)